losartan on a weight basis. In a study designed to assess the incidence of cough in patients receiving losartan as compared to patients being treated with
Persistent dry cough (with an incidence of a few percent) has been These studies demonstrate that the incidence of cough associated with losartan therapy, in
These studies demonstrate that the incidence of cough associated with losartan therapy, in a population that all had cough associated with ACE-
These studies demonstrate that the incidence of cough associated with losartan Losartan potassium tablets may cause the following side effects that may be
These studies demonstrate that the incidence of cough associated with losartan therapy, in a population that all had cough associated with ACE-
The incidence of cough with losartan (18%) was significantly lower than with lisinopril (97%) and similar to that for metolazone (21%). Cough
treated with ACE inhibitors, the incidence of cough reported by patients receiving losartan or hydrochlorothiazide was similar and was
These studies demonstrate that the incidence of cough associated with losartan therapy, in a population Losartan and its principal active metabolite block the
Persistent dry cough (with an incidence of a few percent) has been These studies demonstrate that the incidence of cough associated with losartan therapy, in
Comments